極米科技(688696.SH):減持數過半 百度網訊、百度畢威已減持合計2.15%股份
格隆匯5月12日丨極米科技(688696.SH)公佈,公司於2022年5月12日收到百度網訊、百度畢威發來的《關於減持進度的吿知函》,截至2022年5月12日,百度網訊、百度畢威通過集中競價交易方式合計已減持股份數量74,294股,約佔公司總股本的0.15%,通過大宗交易方式合計已減持股份數量1,000,000股,約佔公司總股本的2%。
2022年3月4日至2022年5月12日期間通過大宗交易和集中競價方式累計減持股份數量107.429萬股,佔計劃減持數量的比例為50.21%,約佔公司總股本的2.15%。本次減持股份數量已過半,減持計劃尚未實施完畢。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.